Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of Fluarix Quadrivalent in Children 6-35 Months
NCT01711736Phase 3Completed
- Sponsor
- GSK
- Start
- Nov 2012
- Primary completion
- Feb 2013
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 3
01
Overview
A Phase 3 trial of influenza virus vaccine, quadrivalent, split virion in influenza, sponsored by GSK. Started Nov 2012; status: completed.
02
Drugs
influenza virus vaccine, quadrivalent, split virion
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01711736.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01711736.